Related Experiment Videos
Retroperitoneal fibrosis accompanying immune thrombocytopenia
P M Wallach1, M T Flannery, H M Adelman
1Department of Internal Medicine, University of South Florida College of Medicine, Tampa 33612.
Abstract:
Retroperitoneal fibrosis represents an idiopathic systemic fibrosing syndrome which leads to the development of progressive hydronephrosis and azotemia (Stewart and Friberg: Southern Medical Journal 77:1185-1187, 1984; Morad et al.: American Journal of Medicine 82:363-366, 1987). Evidence in the literature supports a hypothesis that retroperitoneal fibrosis represents a systemic autoimmune process (Lichon et al.: Journal of Rheumatology 11:373, 374, 1984; Lipman et al.: JAMA 196:204-206, 1966; Littlejohn and Keystone: Journal of Rheumatology 8:665-669, 1981; Katz et al.: American Journal of Clinical Pathology 67:436-439, 1977). We report a case of a patient with retroperitoneal fibrosis, immune thrombocytopenia, presence of antinuclear antibody, and direct Coombs positivity which provides further evidence that retroperitoneal fibrosis is an autoimmune process. Progressive obstructive uropathy related to his fibrosis led to bilateral hydronephrosis and significant renal function impairment. Also, he developed marked immune thrombocytopenia. Treatment with prednisone produced a dramatic response in both platelet count and renal function.
Insights
Retroperitoneal fibrosis, a rare condition, is increasingly linked to autoimmune processes. A case study shows prednisone treatment improved both platelet count and kidney function in a patient with this condition.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Retroperitoneal fibrosis (RPF) is an idiopathic fibrosing syndrome.
- RPF can cause progressive hydronephrosis and azotemia.
- Literature suggests RPF may be a systemic autoimmune process.
Observation:
- A patient presented with RPF, immune thrombocytopenia, antinuclear antibody, and direct Coombs positivity.
- The patient experienced progressive obstructive uropathy, leading to bilateral hydronephrosis and impaired renal function.
- Marked immune thrombocytopenia was also observed in the patient.
Findings:
- The patient's presentation provides further evidence for RPF as an autoimmune disorder.
- Treatment with prednisone resulted in a significant improvement in platelet count.
- Prednisone therapy also led to dramatic recovery of renal function.
Implications:
- This case supports the hypothesis that RPF is an autoimmune condition.
- Early diagnosis and treatment of RPF may prevent severe renal impairment.
- Immunosuppressive therapy, such as with prednisone, can be effective in managing RPF and associated complications.